Plasmat Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Plasmat Biotech
Plasmat Biotech Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 December 2011 and has a history of 13 years and one month. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rama Saraf and Arun Saraf serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33111WB2011PTC170852
-
Company No.
170852
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Dec 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Plasmat Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rama Saraf
|
Director | 14-Mar-2022 | Current |
|
Arun Saraf
|
Director | 19-Dec-2011 | Current |
Financial Performance of Plasmat Biotech.
Plasmat Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plasmat Biotech?
In 2017, Plasmat Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Metis Steel Private LimitedArun Saraf is a mutual person
-
Gee Dee Udyog LlpRama Saraf and Arun Saraf are mutual person
-
Bengal Cycles Private Limited
Rama Saraf and Arun Saraf are mutual person
-
Abhinna Constructions Private Limited
Rama Saraf and Arun Saraf are mutual person
-
Abhinna Aviation Private Limited
Rama Saraf and Arun Saraf are mutual person
-
Abhinna Coal Washeries Private Limited
Rama Saraf and Arun Saraf are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Plasmat Biotech?
Unlock and access historical data on people associated with Plasmat Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plasmat Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plasmat Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
